National Healthcare (NHC)
Market Price (3/11/2026): $157.98 | Market Cap: $2.4 BilSector: Health Care | Industry: Health Care Facilities
National Healthcare (NHC)
Market Price (3/11/2026): $157.98Market Cap: $2.4 BilSector: Health CareIndustry: Health Care Facilities
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.5%, FCF Yield is 6.1% | Key risksNHC key risks include [1] legal and regulatory liabilities stemming from specific claims of patient abuse, Show more. |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 12% | |
| Low stock price volatilityVol 12M is 29% | |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, and Remote Patient Monitoring. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.5%, FCF Yield is 6.1% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 12% |
| Low stock price volatilityVol 12M is 29% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, and Remote Patient Monitoring. |
| Key risksNHC key risks include [1] legal and regulatory liabilities stemming from specific claims of patient abuse, Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Exceptional Q4 2025 Financial Performance: National Healthcare Corporation reported robust results for the fourth quarter and full year ended December 31, 2025, announced on February 26, 2026. The company's net income for Q4 2025 surged to $24.85 million, a significant increase from $6.08 million in the prior year. Basic earnings per share from continuing operations rose to $1.60 from $0.39 a year ago. Full-year 2025 revenue increased by 16.1% to $1.52 billion, with adjusted net income jumping 35% to $104.1 million.
2. Strategic Acquisition Driving Growth: The White Oak Manor acquisition was a key contributor to the company's financial success, specifically driving the 35% increase in adjusted net income for fiscal year 2025 and contributing to overall revenue growth.
Show more
Stock Movement Drivers
Fundamental Drivers
The 16.2% change in NHC stock from 11/30/2025 to 3/10/2026 was primarily driven by a 17.2% change in the company's Net Income Margin (%).| (LTM values as of) | 11302025 | 3102026 | Change |
|---|---|---|---|
| Stock Price ($) | 135.66 | 157.62 | 16.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,501 | 1,518 | 1.1% |
| Net Income Margin (%) | 6.7% | 7.9% | 17.2% |
| P/E Multiple | 20.7 | 20.4 | -1.9% |
| Shares Outstanding (Mil) | 15 | 16 | -0.1% |
| Cumulative Contribution | 16.2% |
Market Drivers
11/30/2025 to 3/10/2026| Return | Correlation | |
|---|---|---|
| NHC | 16.2% | |
| Market (SPY) | -0.9% | 3.1% |
| Sector (XLV) | -2.9% | 30.2% |
Fundamental Drivers
The 40.3% change in NHC stock from 8/31/2025 to 3/10/2026 was primarily driven by a 22.8% change in the company's P/E Multiple.| (LTM values as of) | 8312025 | 3102026 | Change |
|---|---|---|---|
| Stock Price ($) | 112.36 | 157.62 | 40.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,458 | 1,518 | 4.1% |
| Net Income Margin (%) | 7.2% | 7.9% | 10.0% |
| P/E Multiple | 16.6 | 20.4 | 22.8% |
| Shares Outstanding (Mil) | 15 | 16 | -0.3% |
| Cumulative Contribution | 40.3% |
Market Drivers
8/31/2025 to 3/10/2026| Return | Correlation | |
|---|---|---|
| NHC | 40.3% | |
| Market (SPY) | 5.3% | 17.0% |
| Sector (XLV) | 11.9% | 32.3% |
Fundamental Drivers
The 73.0% change in NHC stock from 2/28/2025 to 3/10/2026 was primarily driven by a 47.7% change in the company's P/E Multiple.| (LTM values as of) | 2282025 | 3102026 | Change |
|---|---|---|---|
| Stock Price ($) | 91.11 | 157.62 | 73.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,298 | 1,518 | 16.9% |
| Net Income Margin (%) | 7.9% | 7.9% | 0.7% |
| P/E Multiple | 13.8 | 20.4 | 47.7% |
| Shares Outstanding (Mil) | 15 | 16 | -0.5% |
| Cumulative Contribution | 73.0% |
Market Drivers
2/28/2025 to 3/10/2026| Return | Correlation | |
|---|---|---|
| NHC | 73.0% | |
| Market (SPY) | 15.0% | 29.1% |
| Sector (XLV) | 4.2% | 28.6% |
Fundamental Drivers
The 206.4% change in NHC stock from 2/28/2023 to 3/10/2026 was primarily driven by a 278.5% change in the company's Net Income Margin (%).| (LTM values as of) | 2282023 | 3102026 | Change |
|---|---|---|---|
| Stock Price ($) | 51.44 | 157.62 | 206.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,074 | 1,518 | 41.3% |
| Net Income Margin (%) | 2.1% | 7.9% | 278.5% |
| P/E Multiple | 35.1 | 20.4 | -42.0% |
| Shares Outstanding (Mil) | 15 | 16 | -1.1% |
| Cumulative Contribution | 206.4% |
Market Drivers
2/28/2023 to 3/10/2026| Return | Correlation | |
|---|---|---|
| NHC | 206.4% | |
| Market (SPY) | 77.3% | 32.6% |
| Sector (XLV) | 26.0% | 28.7% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| NHC Return | 5% | -9% | 61% | 19% | 30% | 17% | 179% |
| Peers Return | -2% | -3% | 35% | 7% | 68% | 8% | 150% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -1% | 81% |
Monthly Win Rates [3] | |||||||
| NHC Win Rate | 42% | 42% | 67% | 58% | 67% | 67% | |
| Peers Win Rate | 48% | 50% | 56% | 63% | 65% | 47% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| NHC Max Drawdown | -4% | -13% | -12% | -5% | -16% | -6% | |
| Peers Max Drawdown | -20% | -26% | -14% | -13% | -18% | -6% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -2% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: ENSG, PACS, BKD, ADUS, EHC.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/10/2026 (YTD)
How Low Can It Go
| Event | NHC | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -33.8% | -25.4% |
| % Gain to Breakeven | 51.0% | 34.1% |
| Time to Breakeven | 266 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -35.3% | -33.9% |
| % Gain to Breakeven | 54.5% | 51.3% |
| Time to Breakeven | 1,362 days | 148 days |
| 2018 Correction | ||
| % Loss | -25.0% | -19.8% |
| % Gain to Breakeven | 33.3% | 24.7% |
| Time to Breakeven | 205 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -37.9% | -56.8% |
| % Gain to Breakeven | 60.9% | 131.3% |
| Time to Breakeven | 1,958 days | 1,480 days |
Compare to ENSG, PACS, BKD, ADUS, EHC
In The Past
National Healthcare's stock fell -33.8% during the 2022 Inflation Shock from a high on 3/18/2021. A -33.8% loss requires a 51.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About National Healthcare (NHC)
AI Analysis | Feedback
National Healthcare (NHC) Analogies
- A Marriott for senior living and post-acute care facilities.
- Like a specialized HCA Healthcare, operating nursing homes and assisted living communities instead of acute care hospitals.
AI Analysis | Feedback
- Skilled Nursing Services: Provides post-acute and long-term care, including medical supervision, rehabilitation therapies, and assistance with daily living for patients.
- Assisted Living Services: Offers residential care for individuals who need help with daily activities but do not require complex medical care.
- Independent Living Services: Delivers housing and amenities for active seniors seeking a maintenance-free lifestyle with access to services and social engagement.
- Homecare Services: Supplies medical and non-medical care, such as skilled nursing, therapy, and personal care, directly in patients' homes.
- Hospice Services: Focuses on end-of-life care, providing comfort, pain management, and emotional and spiritual support for patients and their families.
AI Analysis | Feedback
National Healthcare Corporation (NHC) primarily serves individuals directly rather than other companies. Its customers can be categorized as follows:
- Residents of Skilled Nursing and Rehabilitation Facilities: These are individuals, often elderly, who require post-acute care, short-term rehabilitation following a hospital stay, or long-term care for chronic medical conditions.
- Residents of Assisted Living and Independent Living Facilities: This category includes seniors who seek a supportive living environment with assistance for daily activities (assisted living) or those who desire a community setting with amenities and social opportunities without requiring daily medical care (independent living).
- Patients receiving Home Healthcare and Hospice Services: These are individuals who require medical care, therapy, or end-of-life support and comfort care delivered in the convenience and familiarity of their own homes.
AI Analysis | Feedback
nullAI Analysis | Feedback
Stephen F. Flatt, Chief Executive Officer & Inside Director
Stephen F. Flatt was appointed Chief Executive Officer of National HealthCare Corporation effective January 1, 2017. He joined NHC in June 2005 as Senior Vice President – Development and became NHC's President on January 1, 2009. Prior to his time at NHC, he served as President of Lipscomb University from 1997 through June 2005. Before that, he was President of Ezell Harding Christian School in Nashville and Vice President of Financial Affairs and Institutional Planning at Lipscomb University. He received his B.A. degree from David Lipscomb College and his M.S. degree and Ph.D. from George Peabody College of Vanderbilt University.
Brian F. Kidd, Senior Vice President and Chief Financial Officer
Brian F. Kidd joined National HealthCare Corporation in 2008. He was promoted to Senior Vice President and Chief Financial Officer in 2023, having previously served as Vice President of Financial Reporting and Director of Financial Reporting. Before joining NHC, Mr. Kidd accumulated 10 years of experience in public accounting. He is a Certified Public Accountant and earned his B.S. in Accounting from Middle Tennessee State University in 1998.
R. Michael Ussery, President & Chief Operating Officer
R. Michael Ussery serves as the President and Chief Operating Officer of National HealthCare Corporation.
B. Anderson "Andy" Flatt, Senior Vice President & Chief Information Officer
B. Anderson "Andy" Flatt holds the position of Senior Vice President and Chief Information Officer at National HealthCare Corporation.
Vicki L. Dodson, Senior Vice President, Patient Services
Vicki L. Dodson is the Senior Vice President of Patient Services for National HealthCare Corporation.
AI Analysis | Feedback
The key risks to National Healthcare Corporation (NHC) are primarily centered around government regulations and reimbursement, workforce challenges, and legal and regulatory liabilities.
- Dependence on Government Reimbursement Programs and Regulatory Changes: National Healthcare Corporation's financial stability is significantly exposed to potential changes in government healthcare policies, specifically concerning Medicare and Medicaid reimbursement rates and methodologies. The highly regulated nature of the healthcare industry means that modifications to laws and regulations, as well as the government's application of these methodologies, could directly impact NHC's revenue and profitability.
- Workforce Recruitment and Retention Challenges: NHC faces persistent challenges in attracting and retaining qualified healthcare professionals. This issue, common within the broader healthcare industry, can affect the quality of service provided and operational efficiency. The ongoing struggle with workforce recruitment and retention also contributes to increased labor costs, which can negatively impact the company's financial performance.
- Legal and Regulatory Liabilities and Patient Care Claims: The company operates in an environment subject to significant legal claims, patient care liabilities, and rigorous regulatory scrutiny. NHC has faced various lawsuits and deficiency reports concerning issues such as patient abuse, inadequate fall prevention, unsafe living environments, and improper Medicare billing. The potential for substantial legal costs, settlement amounts, and reputational damage from such claims and regulatory non-compliance poses a considerable risk to the business.
AI Analysis | Feedback
null
AI Analysis | Feedback
The addressable markets for National Healthcare Corporation (NHC)'s main products and services in the U.S. are as follows:National Healthcare Corporation (NHC) Addressable Markets (U.S.)
- Skilled Nursing Facilities: The U.S. skilled nursing facility market was estimated at USD 199.72 billion in 2024 and is projected to reach USD 290.02 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.39% from 2025 to 2033. Other estimates place the market at USD 202.4 billion in 2025, anticipated to reach USD 279.9 billion by 2035 with a CAGR of 3.3% between 2025 and 2035. Another source reported the market size at USD 180.95 billion in 2023, projected to reach approximately USD 253.77 billion by 2033, with a CAGR of 3.44% from 2024 to 2033.
- Assisted Living Facilities: The U.S. assisted living facility market size was estimated at USD 44.38 billion in 2024 and is expected to reach USD 93.54 billion by 2033, growing at a CAGR of 8.69% from 2025 to 2033. Another report valued the market at USD 103.5 billion in 2024, predicted to reach USD 182.3 billion by 2034 with a 5.9% CAGR during 2025-2034. One source indicated the market was valued at USD 89.4 billion in 2024 and is projected to expand at a CAGR of 5.4% from 2024 to 2031, reaching USD 129.2 billion by 2031.
- Home Healthcare Services: The U.S. home healthcare services market size was valued at USD 100.95 billion in 2024 and is projected to grow from USD 107.07 billion in 2025 to USD 176.30 billion by 2032, exhibiting a CAGR of 7.4% during the forecast period. Other estimates for the U.S. home healthcare market size include USD 162.35 billion in 2024, expected to reach USD 381.40 billion by 2033, growing at a CAGR of 10.00% from 2025 to 2033. Another report estimated the market at USD 111.2 billion in 2024, growing at a CAGR of 10.2% from 2025 to 2035, reaching USD 317.9 billion by 2035.
- Hospice Services: The U.S. hospice market was valued at USD 29.92 billion in 2024 and is projected to reach USD 39.09 billion by 2030, rising at a CAGR of 4.61%. The estimated market size for the hospice industry in the United States reached USD 34.5 billion in 2022 and is projected to experience an 8.02% CAGR from 2023 to 2030. The market size of Hospices & Palliative Care Centers in the U.S. is USD 39.0 billion in 2025. Other data shows the U.S. Hospice Care Market size was valued at USD 36.89 billion in 2024 and is projected to reach USD 67.44 billion by 2031, growing at a CAGR of 8.64% from 2024 to 2031.
AI Analysis | Feedback
National Healthcare Corporation (NHC) is expected to drive future revenue growth over the next two to three years through several key strategies and market dynamics:
- Strategic Acquisitions: NHC has demonstrated a clear strategy of expanding its operations through acquisitions. The August 2024 acquisition of White Oak Management, Inc. notably contributed to a significant increase in net operating revenues for the third quarter of 2025. This indicates that inorganic growth through the addition of new facilities and managed operations remains a key driver.
- Growth in Same-Facility Net Operating Revenues and Demand for Services: The company has consistently reported an increase in same-facility net operating revenues, with an 8.7% rise in the third quarter of 2025 compared to the prior year. This growth is bolstered by the ongoing high demand for NHC's diverse range of healthcare services, including skilled nursing, therapy, assisted living, independent living, homecare, and hospice care. The increase in average Medicare Advantage per diem also supports this trend.
- Favorable Regulatory Changes and Reimbursement Rates: Positive regulatory developments, such as the projected net increase in Medicare Part A payments for skilled nursing facilities for fiscal year 2026, are expected to enhance NHC's financial performance. Improvements in reimbursement rates, including the increase in average Medicare Advantage per diem, contribute to revenue uplift.
- Expansion into Behavioral Health Services: NHC has identified expansion into the behavioral health sector as a potential area for future growth. This diversification into a high-demand healthcare segment could unlock new revenue streams for the company.
AI Analysis | Feedback
National Healthcare (NHC) Capital Allocation Decisions (Last 3-5 Years)Share Repurchases
- NHC repurchased common stock totaling approximately $2.75 million in 2021, $24.96 million in 2022, and $2.05 million in 2023.
- Year-to-date as of September 30, 2025, the company repurchased 88,738 shares for $9.6 million.
- In August 2022, NHC authorized a new stock repurchase program of up to $25 million, which commenced on August 11, 2022, and expired on August 10, 2023.
Share Issuance
- NHC received proceeds from the issuance of common stock totaling approximately $1.76 million in 2021, $2.10 million in 2022, and $1.48 million in 2023.
- In 2020, proceeds from shares sold due to options exercised amounted to approximately $1.76 million.
Inbound Investments
- NHC received significant government stimulus income from the Provider Relief Fund (PRF), with $63.36 million in 2021 and $11.46 million in 2022.
- As of December 31, 2020, $16.07 million of Provider Relief Fund amounts were received but not yet recognized as income, reflected as a current liability on the balance sheet.
Outbound Investments
- On August 1, 2024, NHC completed the acquisition of the White Oak Senior Living portfolio, a 15-property operation in North and South Carolina, for $220 million. This acquisition expanded NHC's operations into North Carolina and increased its presence in South Carolina, adding 1,928 skilled nursing beds, 48 assisted living units, and 302 independent living units.
- In June 2021, NHC acquired the remaining 24.9% equity interest in Caris, a hospice care business, resulting in a recorded gain of $95.20 million.
Capital Expenditures
- Capital expenditures (purchases of property and equipment) were approximately $34.56 million in 2021, $26.02 million in 2022, and $27.88 million in 2023.
- For the next fiscal year, capital expenditures are forecasted to be $29.67 million.
- The primary focus of these expenditures is on the company's core operations, including skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals.
Latest Trefis Analyses
Trade Ideas
Select ideas related to NHC.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02282026 | QDEL | QuidelOrtho | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 02272026 | CHE | Chemed | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02272026 | LLY | Eli Lilly | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 0.0% | 0.0% | 0.0% |
| 02202026 | HAE | Haemonetics | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 3.5% | 3.5% | 0.0% |
| 02132026 | IQV | IQVIA | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 7.1% | 7.1% | -3.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 104.52 |
| Mkt Cap | 4.4 |
| Rev LTM | 4,126 |
| Op Inc LTM | 224 |
| FCF LTM | 152 |
| FCF 3Y Avg | 105 |
| CFO LTM | 311 |
| CFO 3Y Avg | 230 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 17.8% |
| Rev Chg 3Y Avg | 12.3% |
| Rev Chg Q | 11.2% |
| QoQ Delta Rev Chg LTM | 2.7% |
| Op Mgn LTM | 8.4% |
| Op Mgn 3Y Avg | 7.3% |
| QoQ Delta Op Mgn LTM | 0.4% |
| CFO/Rev LTM | 9.5% |
| CFO/Rev 3Y Avg | 9.7% |
| FCF/Rev LTM | 5.4% |
| FCF/Rev 3Y Avg | 5.5% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 4.4 |
| P/S | 1.5 |
| P/EBIT | 13.8 |
| P/E | 19.8 |
| P/CFO | 14.4 |
| Total Yield | 4.4% |
| Dividend Yield | 0.1% |
| FCF Yield 3Y Avg | 4.0% |
| D/E | 0.2 |
| Net D/E | 0.2 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -3.0% |
| 3M Rtn | 14.1% |
| 6M Rtn | 31.7% |
| 12M Rtn | 67.3% |
| 3Y Rtn | 122.9% |
| 1M Excs Rtn | -0.8% |
| 3M Excs Rtn | 15.6% |
| 6M Excs Rtn | 24.5% |
| 12M Excs Rtn | 49.9% |
| 3Y Excs Rtn | 46.7% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Inpatient services | 1,113 | 957 | 912 | 932 | 931 |
| Homecare and hospice services | 140 | 132 | 129 | 97 | 52 |
| All Other | 54 | 53 | 45 | 45 | 46 |
| Total | 1,307 | 1,142 | 1,086 | 1,074 | 1,028 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Inpatient services | 92 | 42 | 10 | 61 | 58 |
| Homecare and hospice services | 26 | 24 | 22 | 19 | 2 |
| All Other | -28 | -10 | 0 | -30 | -11 |
| Total | 90 | 57 | 32 | 51 | 48 |
Price Behavior
| Market Price | $157.62 | |
| Market Cap ($ Bil) | 2.4 | |
| First Trading Date | 01/20/1987 | |
| Distance from 52W High | -8.8% | |
| 50 Days | 200 Days | |
| DMA Price | $150.18 | $123.55 |
| DMA Trend | up | up |
| Distance from DMA | 5.0% | 27.6% |
| 3M | 1YR | |
| Volatility | 33.1% | 28.6% |
| Downside Capture | -22.32 | 19.23 |
| Upside Capture | 79.42 | 71.26 |
| Correlation (SPY) | 2.5% | 29.6% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.21 | 0.18 | 0.10 | 0.47 | 0.43 | 0.60 |
| Up Beta | 0.88 | 1.79 | 1.81 | 1.77 | 0.59 | 0.69 |
| Down Beta | -0.28 | -0.76 | -0.73 | -0.06 | 0.26 | 0.48 |
| Up Capture | 63% | 90% | 61% | 87% | 57% | 52% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 13 | 23 | 35 | 68 | 137 | 406 |
| Down Capture | -189% | -66% | -67% | -16% | 16% | 71% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 8 | 18 | 26 | 56 | 114 | 341 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NHC | |
|---|---|---|---|---|
| NHC | 74.0% | 28.5% | 1.93 | - |
| Sector ETF (XLV) | 4.0% | 17.5% | 0.07 | 28.5% |
| Equity (SPY) | 18.7% | 19.1% | 0.77 | 29.5% |
| Gold (GLD) | 79.6% | 26.2% | 2.22 | -2.4% |
| Commodities (DBC) | 19.2% | 17.2% | 0.88 | 4.2% |
| Real Estate (VNQ) | 5.3% | 16.4% | 0.14 | 32.9% |
| Bitcoin (BTCUSD) | -20.4% | 45.5% | -0.36 | 6.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NHC | |
|---|---|---|---|---|
| NHC | 21.2% | 27.2% | 0.72 | - |
| Sector ETF (XLV) | 8.0% | 14.5% | 0.37 | 32.4% |
| Equity (SPY) | 13.7% | 17.0% | 0.64 | 32.8% |
| Gold (GLD) | 24.5% | 17.2% | 1.16 | 0.3% |
| Commodities (DBC) | 11.6% | 19.0% | 0.50 | 3.9% |
| Real Estate (VNQ) | 5.3% | 18.8% | 0.19 | 33.3% |
| Bitcoin (BTCUSD) | 6.5% | 56.8% | 0.33 | 11.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NHC | |
|---|---|---|---|---|
| NHC | 12.6% | 27.6% | 0.47 | - |
| Sector ETF (XLV) | 10.3% | 16.5% | 0.51 | 38.2% |
| Equity (SPY) | 14.9% | 17.8% | 0.72 | 39.7% |
| Gold (GLD) | 15.1% | 15.6% | 0.81 | -0.1% |
| Commodities (DBC) | 8.9% | 17.6% | 0.42 | 11.9% |
| Real Estate (VNQ) | 5.9% | 20.7% | 0.25 | 41.1% |
| Bitcoin (BTCUSD) | 66.0% | 66.8% | 1.05 | 11.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/27/2026 | 2.1% | 4.9% | |
| 11/7/2025 | 1.7% | 1.3% | 7.1% |
| 8/8/2025 | 4.1% | 10.3% | 20.2% |
| 5/9/2025 | 6.2% | 12.6% | 10.4% |
| 2/27/2025 | -0.2% | 0.6% | -0.3% |
| 11/12/2024 | -3.8% | -8.7% | -9.6% |
| 8/9/2024 | 1.4% | 6.9% | 0.0% |
| 5/10/2024 | -1.1% | 3.4% | 6.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 17 | 18 | 15 |
| # Negative | 7 | 6 | 8 |
| Median Positive | 2.3% | 4.5% | 8.2% |
| Median Negative | -1.1% | -2.8% | -4.6% |
| Max Positive | 7.4% | 13.0% | 27.1% |
| Max Negative | -3.8% | -12.3% | -9.6% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/26/2026 | 10-K |
| 09/30/2025 | 11/06/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/08/2025 | 10-Q |
| 12/31/2024 | 02/28/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-Q |
| 03/31/2024 | 05/09/2024 | 10-Q |
| 12/31/2023 | 02/16/2024 | 10-K |
| 09/30/2023 | 11/02/2023 | 10-Q |
| 06/30/2023 | 08/03/2023 | 10-Q |
| 03/31/2023 | 05/04/2023 | 10-Q |
| 12/31/2022 | 02/17/2023 | 10-K |
| 09/30/2022 | 11/03/2022 | 10-Q |
| 06/30/2022 | 08/04/2022 | 10-Q |
| 03/31/2022 | 05/05/2022 | 10-Q |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Shelly, Timothy J | Sr.VP Operations | Direct | Sell | 12182025 | 139.42 | 2,454 | Form | ||
| 2 | Hassan, Emil E | Direct | Sell | 11262025 | 138.52 | 7,500 | 1,038,873 | 9,085,983 | Form | |
| 3 | Flatt, Stephen Fowler | CEO | Direct | Sell | 11252025 | 130.33 | 1,000 | 130,330 | 7,706,413 | Form |
| 4 | Hassan, Emil E | Direct | Sell | 11122025 | 133.00 | 5,500 | 731,500 | 9,721,635 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.